Back to ROIV
KBC Group NV ROIV Position History
Roivant Sciences Ltd. • Healthcare
Quarters held
6
Latest value
$48K
Q3 2026
Peak value
$2.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $161K |
| Q4 2025 | $272K |
| Q1 2026 | $325K |
| Q2 2026 | $463K |
| Q3 2026 | $2.9M |
| Q3 2026 | $48K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $48K | 1.3K | — | — |
| Q3 2026 | $2.9M | 79.8K | — | — |
| Q2 2026 | $463K | 13.1K | — | — |
| Q1 2026 | $325K | 11.7K | — | — |
| Q4 2025 | $272K | 12.5K | — | — |
| Q3 2025 | $161K | 10.7K | — | — |
Other funds holding ROIV
$1.2B
$1.2B
$857.7M
$841.4M
$758.4M